q2 adjusted earnings per share $1.05.
qtrly revenue decreased 1 percent to $37.9 million, or $6.5 million.
qtrly scientific revenue increased 16% year-on-year.
qtrly organic revenue decreased 4.3 percent.
q2 revenue rose 31.2 percent to $60.1 million.
qtrly specialty solutions revenue decreased 17.8% to $22.8 million.
expect capital expenditures for fiscal 2021 to be between $25 million and $28 million.
qtrly engineering technologies revenue decreased 33.9% to $17.5 million and operating income decreased 60.2%.
now believes that covid related storage demand is likely to be at higher end of previously indicated $10 million to $20 million range in fiscal 2021.
qtrly sales increased 31% to $1.4 billion.
qtrly total revenue rose 1.7 percent to $1.7 billion.
compname says assumes a tax rate in mid 20% range in q3 of 2021, and a low 20% rate in q4 of 2021.
q2 earnings per share $0.22.
expect covid vaccine storage demand to come in at high end of previously indicated $10 million to $20 million sales range in fiscal 2021.
qtrly scientific segment revenue of $17.9 million, up 16.1% year-on-year.
sees fy 2021 adjusted earnings per share about 22%.
